RVT vs. NVS

Last updated Jun 13, 2026

RVT (Royce Value Trust Inc.) and NVS (Novartis AG) are both stocks. RVT operates in Asset Management (Financial Services), while NVS operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, RVT returned 13.17%/yr vs 11.14%/yr for NVS. At a 0.31 correlation, their price movements are largely independent.

Performance

RVT vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Royce Value Trust Inc. (RVT) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RVT achieves a 15.52% return, which is significantly higher than NVS's 14.40% return. Over the past 10 years, RVT has outperformed NVS with an annualized return of 13.17%, while NVS has yielded a comparatively lower 11.14% annualized return.

RVT

• 1D: 2.22%
• 1M: -1.06%
• YTD: 15.52%
• 6M: 15.09%
• 1Y: 31.26%
• 3Y*: 19.04%
• 5Y*: 7.50%
• 10Y*: 13.17%

NVS

• 1D: -0.55%
• 1M: 2.22%
• YTD: 14.40%
• 6M: 18.98%
• 1Y: 30.60%
• 3Y*: 19.57%
• 5Y*: 14.77%
• 10Y*: 11.14%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RVT vs. NVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RVT Royce Value Trust Inc.	15.52%	11.54%	17.93%	18.79%	-26.25%	32.66%	18.16%	35.41%	-20.70%	30.63%
NVS Novartis AG	14.40%	46.95%	0.02%	16.14%	8.06%	-3.65%	3.34%	13.92%	5.95%	19.42%

Correlation

The correlation between RVT and NVS is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.30
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (10Y) Calculated over the trailing 10-year period	0.31
Correlation (All Time) Calculated using the full available price history since Nov 7, 1996	0.31

Fundamentals

Market Cap RVT : $2.16B NVS : $293.28B
EPS RVT : $4.02 NVS : $6.99
PE Ratio RVT : 4.47 NVS : 21.90
PS Ratio RVT : 12.65 NVS : 5.29
PB Ratio RVT : 1.00 NVS : 7.62
Total Revenue (TTM) RVT : $170.31M NVS : $56.05B
Gross Profit (TTM) RVT : $304.06M NVS : $42.19B
EBITDA (TTM) RVT : $439.27M NVS : $22.40B

Return for Risk

RVT vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVT

RVT Risk / Return Rank: 84
RVT Sharpe Ratio Rank: 86
RVT Sortino Ratio Rank: 83
RVT Omega Ratio Rank: 81
RVT Calmar Ratio Rank: 81
RVT Martin Ratio Rank: 87

NVS

NVS Risk / Return Rank: 80
NVS Sharpe Ratio Rank: 82
NVS Sortino Ratio Rank: 79
NVS Omega Ratio Rank: 77
NVS Calmar Ratio Rank: 80
NVS Martin Ratio Rank: 80

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVT vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Royce Value Trust Inc. (RVT) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RVT	NVS	Difference
Sharpe ratio: Return per unit of total volatility	1.71	1.47	+0.24
Sortino ratio: Return per unit of downside risk	2.41	2.10	+0.31
Omega ratio: Gain probability vs. loss probability	1.29	1.26	+0.04
Calmar ratio: Return relative to maximum drawdown	2.58	2.43	+0.15
Martin ratio: Return relative to average drawdown	9.08	5.88	+3.20

RVT vs. NVS - Sharpe Ratio Comparison

The current RVT Sharpe Ratio is 1.71, which is comparable to the NVS Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of RVT and NVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RVT vs. NVS - Drawdown Comparison

The maximum RVT drawdown since its inception was -72.34%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for RVT and NVS.

Drawdown Indicators

	RVT	NVS	Difference
Max Drawdown Largest peak-to-trough decline	-72.34%	-42.10%	-30.24%
Max Drawdown (1Y) Largest decline over 1 year	-12.19%	-12.65%	+0.46%
Max Drawdown (3Y) Largest decline over 3 years	-23.48%	-19.95%	-3.53%
Max Drawdown (5Y) Largest decline over 5 years	-32.79%	-20.42%	-12.37%
Max Drawdown (10Y) Largest decline over 10 years	-47.18%	-26.03%	-21.15%
Current Drawdown Current decline from peak	-2.59%	-6.46%	+3.87%
Average Drawdown Average peak-to-trough decline	-11.29%	-10.92%	-0.37%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.46%	5.23%	-1.77%

Volatility

RVT vs. NVS - Volatility Comparison

The current volatility for Royce Value Trust Inc. (RVT) is 6.60%, while Novartis AG (NVS) has a volatility of 7.18%. This indicates that RVT experiences smaller price fluctuations and is considered to be less risky than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RVT	NVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.60%	7.18%	-0.58%
Volatility (6M) Calculated over the trailing 6-month period	13.90%	14.96%	-1.06%
Volatility (1Y) Calculated over the trailing 1-year period	18.35%	21.02%	-2.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.50%	18.89%	+3.61%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.99%	19.64%	+3.35%

Dividends

RVT vs. NVS - Dividend Comparison

RVT's dividend yield for the trailing twelve months is around 8.02%, more than NVS's 3.12% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVS Novartis AG	3.12%	2.90%	3.84%	3.44%	3.70%	3.86%	3.22%	3.03%	3.47%	3.24%	3.73%	3.10%
RVT Royce Value Trust Inc.	8.02%	8.82%	8.04%	7.35%	9.95%	8.52%	6.44%	7.45%	10.68%	7.17%	7.62%	10.54%

Financials

Frequently Asked Questions

Can I hold both RVT and NVS in my portfolio?

RVT and NVS have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RVT or NVS?

NVS has higher volatility (7.18%) compared to RVT (6.60%). In terms of maximum drawdown, RVT dropped -72.34% vs NVS's -42.10%.

Which has better risk-adjusted returns?

RVT currently has the higher Sharpe Ratio (1.71 vs 1.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.